CALC: CalciMedica, Inc. Stock

by  •  • Comments Off on CALC: CalciMedica, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 20.76
Enterprise Value ($M) 12.83
Book Value ($M) 14.41
Book Value / Share 1.07
Price / Book 1.44
NCAV ($M) 14.28
NCAV / Share 1.06
Price / NCAV 1.45

Profitability (mra)
Return on Invested Capital (ROIC) -0.95
Return on Assets (ROA) -0.50
Return on Equity (ROE) -0.79

Liquidity (mrq)
Quick Ratio 5.34
Current Ratio 5.34

Balance Sheet (mrq) ($M)
Current Assets 19.66
Assets 19.79
Liabilities 5.38
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -24.20
Net Income -13.70

Cash Flow Statement (mra) ($M)
Cash From Operations -21.15
Cash from Investing -4.42
Cash from Financing 27.97

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
04-01 13G Alafi Capital Co Llc 9.60
03-03 13G/A Aisling Capital V, LP 3.90 -25.00
02-14 13G/A Leerink Revelation Healthcare Fund I, L.p. 0.00 -100.00
12-13 13G Stonepine Capital Management, LLC 5.40
11-26 13D Sanderling Venture Partners VI LP 18.30
11-14 13G/A Soleus Private Equity Fund III, L.P. 8.50
11-14 13G/A Lytton Laurence W 4.40 -37.99
11-06 13D/A Valence Investments SPV VI, LLC 9.00 4.67

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-03-27 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2024-11-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-08-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-05-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-04-29 10-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K/A (AMENDMENT NO. 1) (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 or ☐ T

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-04-17 977 4,241 23.04
2025-04-16 5,249 14,242 36.86
2025-04-15 1,531 4,966 30.83
2025-04-14 6,232 12,538 49.70

(click for more detail)

Similar Companies
BTAI – BioXcel Therapeutics, Inc. BULL – Webull Corporation
BYSI – BeyondSpring Inc. CAPR – Capricor Therapeutics, Inc.
CASI – CASI Pharmaceuticals, Inc.


Financial data and stock pages provided by
Fintel.io